FDA 21 CFR Part 11

Master this essential documentation concept

Quick Definition

A U.S. Food and Drug Administration regulation that defines the criteria under which electronic records and electronic signatures are considered trustworthy and equivalent to paper records.

How FDA 21 CFR Part 11 Works

flowchart TD A[Document Created] --> B{Electronic Record?} B -->|Yes| C[Apply Part 11 Controls] B -->|No| D[Paper Process] C --> E[Access Control\nUser Authentication] E --> F[Document Authoring\nin Validated System] F --> G[Version Control\nLocked Metadata] G --> H{Requires Signature?} H -->|Yes| I[Electronic Signature\nID + Password] H -->|No| J[Record Stored] I --> K[Signature Manifest\nName + Date + Meaning] K --> L[Audit Trail\nAuto-Generated] L --> M[Record Archived\nTamper-Evident] M --> N{FDA Inspection} N --> O[Retrieve Audit Trail] N --> P[Verify Signatures] N --> Q[System Validation Docs] O --> R[Compliance Demonstrated] P --> R Q --> R style A fill:#4A90D9,color:#fff style C fill:#E8A838,color:#fff style R fill:#27AE60,color:#fff style I fill:#8E44AD,color:#fff

Understanding FDA 21 CFR Part 11

FDA 21 CFR Part 11, enacted in 1997, is a critical regulatory framework governing how life sciences organizations manage electronic records and signatures. For documentation professionals working in pharmaceutical, biotech, or medical device companies, understanding and implementing this regulation is essential to maintaining regulatory compliance and ensuring data integrity across all documentation workflows.

Key Features

  • Audit Trails: All electronic records must include time-stamped, computer-generated audit trails that capture who created, modified, or deleted a record and when
  • Electronic Signature Controls: Signatures must be unique to individuals, require at least two identification components (e.g., ID and password), and cannot be reused or reassigned
  • System Validation: All software used to create or manage electronic records must be validated to ensure accuracy, reliability, and consistent performance
  • Access Controls: Systems must limit access to authorized individuals through role-based permissions and user authentication protocols
  • Record Integrity: Electronic records must be protected from unauthorized alteration, with controls ensuring records remain accurate and retrievable throughout their retention period
  • Closed vs. Open Systems: The regulation distinguishes between closed systems (controlled by record creators) and open systems (internet-accessible), with stricter requirements for open systems

Benefits for Documentation Teams

  • Eliminates paper-based workflows, reducing physical storage costs and retrieval time
  • Provides a clear, defensible chain of custody for all document changes and approvals
  • Enables remote collaboration and digital approvals without sacrificing regulatory compliance
  • Streamlines FDA inspections by providing instant access to complete, organized audit trails
  • Reduces transcription errors associated with manual paper processes
  • Supports faster document approval cycles through compliant e-signature workflows

Common Misconceptions

  • Myth: Any e-signature tool is compliant. Reality: E-signature platforms must meet specific Part 11 criteria including unique identification, non-repudiation, and system validation
  • Myth: Part 11 only applies to final documents. Reality: It applies to all electronic records used to demonstrate compliance, including drafts, logs, and metadata
  • Myth: Compliance is a one-time effort. Reality: Ongoing validation, periodic audits, and continuous training are required to maintain compliance
  • Myth: Cloud-based systems cannot be Part 11 compliant. Reality: Cloud systems can be fully compliant when properly validated and configured with appropriate controls

Meeting FDA 21 CFR Part 11 Audit Trails When Your Process Knowledge Lives in Videos

Many regulated teams document their electronic records and signature workflows by recording screen walkthroughs or live demonstrations — a practical way to capture nuanced system behavior that is difficult to describe in writing. A subject matter expert walks through the validation steps, shows how audit trails are generated, and explains how your electronic signatures meet FDA 21 CFR Part 11 requirements. The recording gets saved, shared once, and gradually forgotten.

The problem is that FDA 21 CFR Part 11 compliance depends on traceable, reviewable, and consistently followed procedures — not institutional memory locked inside a video file. During an audit, inspectors expect written SOPs that staff can reference, follow step-by-step, and sign off on. A video cannot be version-controlled, cannot carry an effective date, and cannot be searched for a specific validation criterion at 9 AM on inspection day.

Converting those process walkthrough videos into structured SOPs gives your team the documented evidence trail that FDA 21 CFR Part 11 demands. For example, a screen-recorded validation walkthrough becomes a numbered procedure with defined inputs, expected system responses, and signature checkpoints — exactly the format auditors expect to see. Your team gets documentation that is searchable, assignable, and audit-ready without starting from a blank page.

If your compliance workflows still rely on video recordings as your primary procedure reference, see how converting them into formal SOPs can close that gap.

Real-World Documentation Use Cases

Standard Operating Procedure (SOP) Approval Workflow

Problem

A pharmaceutical company's quality team manages hundreds of SOPs that require multi-level review and approval. Paper-based signatures cause delays of weeks, create storage challenges, and make it difficult to prove document approval status during FDA audits.

Solution

Implement a Part 11-compliant documentation platform with electronic signature workflows that capture unique user credentials, timestamps, and signature meaning (e.g., 'Approved', 'Reviewed') for every SOP approval action.

Implementation

1. Select and validate a Part 11-compliant document management system. 2. Configure role-based access for authors, reviewers, and approvers. 3. Set up electronic signature workflows requiring username and password authentication. 4. Enable automatic audit trail generation for all document actions. 5. Define signature manifestations that include signer name, date/time, and signature meaning. 6. Train all users on compliant signature procedures. 7. Document system validation in an IQ/OQ/PQ protocol.

Expected Outcome

SOP approval cycles reduced from 3 weeks to 3 days, complete audit trails available instantly during inspections, and zero paper storage costs for document archives.

Batch Record Documentation in Manufacturing

Problem

A biotech manufacturer uses paper batch records that are prone to transcription errors, illegible handwriting, and missing signatures. During an FDA inspection, incomplete records resulted in a Form 483 observation.

Solution

Transition to electronic batch records (EBRs) within a validated, Part 11-compliant system that enforces mandatory field completion, captures real-time data entries, and requires electronic signatures at each critical step.

Implementation

1. Map all existing paper batch record fields to electronic equivalents. 2. Validate the EBR system per FDA guidance. 3. Configure mandatory fields to prevent incomplete record submission. 4. Implement 21 CFR Part 11-compliant e-signatures for each process step requiring sign-off. 5. Enable automated audit trails capturing operator ID, timestamp, and data entered. 6. Establish a backup and recovery procedure for electronic records. 7. Train manufacturing staff and document training records.

Expected Outcome

Elimination of transcription errors, 100% complete records at batch release, reduced review time by 60%, and successful FDA inspection with no data integrity observations.

Clinical Trial Document Management

Problem

A CRO managing multi-site clinical trials struggles with version control of investigator documents, informed consent forms, and protocol amendments. Different sites use different document versions, creating compliance risks and potential patient safety issues.

Solution

Deploy a Part 11-compliant eTMF (electronic Trial Master File) system that centralizes document management, enforces version control, and captures electronic signatures from investigators at all sites.

Implementation

1. Implement a validated eTMF platform meeting Part 11 and ICH E6 R2 requirements. 2. Establish a document hierarchy with controlled distribution to all sites. 3. Configure automatic version locking when documents are approved. 4. Set up site-specific access controls so investigators only see current, approved versions. 5. Enable electronic signature capture for investigator acknowledgment of protocol amendments. 6. Generate automated notifications when new document versions are approved. 7. Maintain complete audit trails of document distribution and acknowledgment.

Expected Outcome

All sites consistently using current document versions, complete audit trail of investigator acknowledgments, faster protocol amendment implementation, and streamlined regulatory submission preparation.

Change Control Documentation for Medical Devices

Problem

A medical device company's change control process involves multiple departments reviewing design changes. Paper routing slips get lost, approvals are delayed, and reconstructing the change history during a 510(k) submission is time-consuming and error-prone.

Solution

Implement a Part 11-compliant change control system within a validated document management platform that routes change requests electronically, captures all review comments, and maintains a complete, immutable change history.

Implementation

1. Configure a validated document management system with change control module. 2. Design electronic change request forms capturing all required fields. 3. Set up automated routing workflows based on change type and impact assessment. 4. Require electronic signatures from each approver with defined signature meaning. 5. Enable threaded commenting with timestamps for review discussions. 6. Link change records to affected documents, drawings, and specifications. 7. Generate automated change history reports for regulatory submissions.

Expected Outcome

Change approval cycle time reduced by 45%, complete traceability from change request to implementation, simplified 510(k) submission preparation, and successful ISO 13485 and FDA audit outcomes.

Best Practices

Validate Your Documentation System Before Go-Live

System validation is a foundational requirement of 21 CFR Part 11. Every software system used to create, modify, maintain, or transmit electronic records must be formally validated to demonstrate it consistently performs as intended. This includes commercial off-the-shelf (COTS) software and cloud-based platforms.

✓ Do: Develop and execute Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) protocols. Document all validation activities, maintain validation records, and revalidate after significant system changes or upgrades. Work with your vendor to obtain their validation documentation package.
✗ Don't: Do not assume a vendor's SOC 2 certification or ISO 27001 compliance substitutes for Part 11 validation. Never skip revalidation after software updates, configuration changes, or infrastructure migrations, as these can introduce new risks to system integrity.

Design Audit Trails That Capture Meaningful Data

Audit trails must be computer-generated, time-stamped, and capture the date and time of operator entries and actions that create, modify, or delete electronic records. The audit trail must be retained for the same period as the records it supports and must be available for FDA review.

✓ Do: Configure your system to automatically capture user ID, action performed, timestamp (with time zone), original value, and new value for every record modification. Ensure audit trails are stored separately from the records they document and cannot be modified by regular users. Regularly review audit trails as part of your quality oversight process.
✗ Don't: Do not allow users to disable, modify, or delete audit trail entries. Avoid systems where audit trails are stored in the same editable location as the records themselves, and never configure systems to overwrite audit trail data after a set period without regulatory justification.

Implement Rigorous Electronic Signature Controls

Part 11 requires that electronic signatures be unique to one individual and not reused or reassigned. Each signature must employ at least two distinct identification components such as an identification code and password. Signers must certify that their electronic signatures are the legally binding equivalent of handwritten signatures.

✓ Do: Require users to re-enter their credentials at the time of signing rather than relying on session authentication alone. Implement signature manifestations that display the printed name of the signer, date and time of signing, and the meaning of the signature (e.g., 'Author', 'Reviewer', 'Approver'). Maintain signed records with the signature information permanently linked to the document.
✗ Don't: Do not allow shared accounts or generic logins for document signing. Never implement signature workflows where a single authentication (login) covers multiple signature actions performed at different times, and avoid systems where signature credentials can be delegated or transferred to another user.

Establish and Enforce Access Control Procedures

Part 11 requires that system access be limited to authorized individuals through operational and technical controls. This includes unique user IDs, strong password policies, role-based permissions, and procedures for managing user access throughout the employee lifecycle including onboarding, role changes, and offboarding.

✓ Do: Implement role-based access control (RBAC) that grants users only the minimum permissions necessary for their job function. Establish formal procedures for user provisioning and deprovisioning, conduct periodic access reviews (at least annually), and enforce strong password policies including complexity requirements and expiration intervals. Log and review all failed login attempts.
✗ Don't: Do not allow generic, shared, or departmental login accounts for accessing Part 11 systems. Avoid delaying the removal of system access for terminated employees or those who change roles, and never grant administrative-level access to users who do not require it for their documented job responsibilities.

Develop and Maintain Comprehensive SOPs for Electronic Records

Part 11 compliance requires not just technical controls but also documented procedures governing how electronic records and signatures are used. These SOPs must address system use, signature procedures, record retention, backup and recovery, and incident response. Staff must be trained on these procedures and training must be documented.

✓ Do: Create specific SOPs covering: electronic signature policy, system access management, audit trail review, record backup and recovery, periodic system review, and handling of system failures. Conduct initial and refresher training for all users, document training completion in a learning management system, and include Part 11 compliance in your quality management system. Review SOPs at least annually.
✗ Don't: Do not rely solely on technical system controls without supporting procedural documentation. Avoid treating Part 11 compliance as an IT-only responsibility — quality, regulatory affairs, and documentation teams must all be actively involved. Never allow staff to use Part 11-regulated systems without documented, current training on compliant procedures.

How Docsie Helps with FDA 21 CFR Part 11

Build Better Documentation with Docsie

Join thousands of teams creating outstanding documentation

Start Free Trial